Finance entity
Every one of those 1 sits in a single category, markets. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window.
Last mentioned: Mar 15, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, markets. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Hologic, Inc. appears in 1 tracked Finance story from March 15, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 82 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Hologic, Inc. (NASDAQ: HOLX) has experienced a dramatic 71.7% increase in short interest, signaling a sharp pivot in investor sentiment toward the medical technology leader. This surge in bearish positioning suggests growing market skepticism regarding the company's growth trajectory in a post-pandemic diagnostic landscape.
Hologic, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
